Detalhe da pesquisa
1.
Randomized comparison between KTd and KRd induction therapy followed by maintenance therapy with K or observation in transplant-ineligible patients with newly diagnosed multiple myeloma.
Am J Hematol
; 99(5): 1008-1011, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38425185
2.
Bone marrow microenvironment- induced regulation of Bcl-2 family members in multiple myeloma (MM): Therapeutic implications.
Cytokine
; 161: 156062, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36332463
3.
Oral Selinexor-Dexamethasone for Triple-Class Refractory Multiple Myeloma.
N Engl J Med
; 381(8): 727-738, 2019 08 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-31433920
4.
Essential role of the histone lysine demethylase KDM4A in the biology of malignant pleural mesothelioma (MPM).
Br J Cancer
; 125(4): 582-592, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34088988
5.
Effect of cachexia on bone turnover in cancer patients: a case-control study.
BMC Cancer
; 21(1): 744, 2021 Jun 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34182958
6.
Quality of life analyses in patients with multiple myeloma: results from the Selinexor (KPT-330) Treatment of Refractory Myeloma (STORM) phase 2b study.
BMC Cancer
; 21(1): 993, 2021 Sep 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34488662
7.
Retraction: Ku86 Variant Expression and Function in Multiple Myeloma Cells Is Associated with Increased Sensitivity to DNA Damage.
J Immunol
; 212(8): 1392, 2024 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38416013
8.
Targeting mtDAMPed macrophages for MM therapy.
Blood
; 141(25): 3012-3014, 2023 06 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37347499
9.
Correction: Mcl-1 confers protection of Her2-positive breast cancer cells to hypoxia: therapeutic implications.
Breast Cancer Res
; 26(1): 58, 2024 Apr 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38566222
10.
Rationally derived drug combinations with the novel Mcl-1 inhibitor EU-5346 in breast cancer.
Breast Cancer Res Treat
; 173(3): 585-596, 2019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-30374681
11.
Emerging protein kinase inhibitors for the treatment of multiple myeloma.
Expert Opin Emerg Drugs
; 24(3): 133-152, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31327278
12.
The orally available multikinase inhibitor regorafenib (BAY 73-4506) in multiple myeloma.
Ann Hematol
; 97(5): 839-849, 2018 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-29359239
13.
Toward optimizing pomalidomide therapy in MM patients.
Blood
; 125(26): 3968-9, 2015 Jun 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-26113530
14.
Mcl-1 confers protection of Her2-positive breast cancer cells to hypoxia: therapeutic implications.
Breast Cancer Res
; 18(1): 26, 2016 Feb 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-26921175
15.
Targeting the Bone Marrow Microenvironment.
Cancer Treat Res
; 169: 63-102, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27696259
16.
The preclinical discovery and clinical development of ciltacabtagene autoleucel (Cilta-cel) for the treatment of multiple myeloma.
Expert Opin Drug Discov
; 19(4): 377-391, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38369760
17.
Favorable impact of PD1/PD-L1 antagonists on bone remodeling: an exploratory prospective clinical study and ex vivo validation.
J Immunother Cancer
; 12(5)2024 May 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38702145
18.
A novel orally active proteasome inhibitor induces apoptosis in multiple myeloma cells with mechanisms distinct from Bortezomib.
Cancer Cell
; 8(5): 407-19, 2005 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-16286248
19.
Evaluation of Antibody Responses in Patients with B-Cell Malignancies after Two and Three Doses of Anti-SARS-CoV-2 S Vaccination-A Retrospective Cohort Study.
Cancers (Basel)
; 15(2)2023 Jan 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36672473
20.
Attrition Rates in Multiple Myeloma Treatment under Real World Conditions-An Analysis from the Austrian Myeloma Registry (AMR).
Cancers (Basel)
; 15(3)2023 Feb 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36765918